Wave Life Sciences to Present at the 2023 Virtual SVB Securities Global Biopharma Conference

Rhea-AI Summary

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company, announced that CEO Paul Bolno will participate in a fireside chat at the SVB Securities Global Biopharma Conference on February 16, 2023, at 10:00 a.m. ET.

The event will be streamed live and available for later viewing on the company's Investor Relations page. Wave Life Sciences is focused on developing life-changing treatments for genetically defined diseases using its PRISM platform, which facilitates the design and production of stereopure oligonucleotides.

CAMBRIDGE, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the SVB Securities Global Biopharma Conference at 10:00 a.m. ET on Thursday, February, 16, 2023.

A live webcast of this presentation can be found here and will also be available on the Investor Relations page of the Wave Life Sciences corporate website at http://ir.wavelifesciences.com. Replays of this presentation will be archived and available on the site for a limited time following the event.

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contact:
Kate Rausch
617-949-4827
InvestorRelations@wavelifesci.com

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com

FAQ

What is the schedule for Wave Life Sciences CEO's presentation at the SVB Securities Global Biopharma Conference?

Paul Bolno, CEO of Wave Life Sciences, is scheduled to present on February 16, 2023, at 10:00 a.m. ET.

How can I watch the Wave Life Sciences presentation at the conference?

The presentation will be live-streamed and archived on Wave Life Sciences' Investor Relations page.

What is Wave Life Sciences' focus as a company?

Wave Life Sciences focuses on developing genetic medicines for devastating diseases using its proprietary PRISM platform.

Where can I find more information about Wave Life Sciences?

More information about Wave Life Sciences can be found on their official website at www.wavelifesciences.com.

What is the stock symbol for Wave Life Sciences?

The stock symbol for Wave Life Sciences is WVE.